Skip to main content
Top

Breast Cancer Research and Treatment

Issue 3/2006

Content (14 Articles)

Preclinical Study

Direct-to-patient BRCA1 testing: the Twoj Styl experience

Jacek Gronwald, Tomasz Huzarski, Tomasz Byrski, Tadeusz Dębniak, Kelly Metcalfe, Steven A. Narod, Jan Lubiński

CLINICAL TRIAL

Computed tomography in suspected local breast cancer recurrence

F. Ternier, G. Houvenaeghel, F. Lecrivain, B. Le Brigand, D. Margain, S. Brunelle, D. Di Stefano

Clinical Trial

Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy

Michelle Shayne, Jeffrey Crawford, David C. Dale, Eva Culakova, Gary H. Lyman

Clinical Trial

Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19

Jianhua Liu, Dongsheng Tu, Janet Dancey, Leonard Reyno, Kathleen I. Pritchard, Joseph Pater, Lesley K Seymour

Epidemiology

Cigarette smoking and breast cancer risk: update of a prospective cohort study

Yan Cui, Anthony B. Miller, Thomas E. Rohan

Original Paper

Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806

Mercedes Rincon, Gloria Broadwater, Lyndsay Harris, Abigail Crocker, Donald Weaver, Lynn Dressler, Donald Berry, Linda Sutton, Richard Michaelson, Michael Messino, Jeffrey Kirshner, Gini Fleming, Eric Winer, Clifford Hudis, Stacy Appel, Larry Norton, Hyman Muss

Original report

Variation in false-positive rates of mammography reading among 1067 radiologists: a population-based assessment

Alai Tan, Daniel H. Freeman Jr., James S. Goodwin, Jean L. Freeman

Clinical Epidemiology

Is risk of axillary lymph node metastasis associated with proximity of breast cancer to the skin?

Joan E. Cunningham, Adriana L. Jurj, Leah Oman, Amy E. Stonerock, Daniela K. Nitcheva, Tommy E. Cupples

Letter to the Editor

Lack of Association Between NOS3 Glu298Asp and Breast Cancer Risk: a Case–ontrol Study

Jose Luis Royo, José Andrés Moreno-Nogueira, Jose Jorge Galán, Antonio González-Martín, Agustin Ruiz, Rosario González-Mancha, Luis Miguel Real

Letter to the Editor

A high risk of occurrence of sporadic breast cancer in individuals with the 104NN polymorphism of the COL18A1 gene

Gustavo J. Lourenço, Cassio Cardoso-Filho, Neiva S. L. Gonçales, Julia Y. Shinzato, Luis C. Zeferino, Helvia Nascimento, Fernando F. Costa, Maria S. C. Gurgel, Carmen S. P. Lima

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine